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ACUTE RESPIRATORY DISTRESS SYNDROME AFTER
EARLY SUCCESSFUL PRIMARY PERCUTANEOUS
CORONARY INTERVENTION THERAPY IN ACUTE
MYOCARDIAL INFARCTION: A CASE REPORT
Ho-Ming Su, Wen-Chol Voon, Tsung-Hsien Lin, Chih-Sheng Chu, Sheng-Hsiung Sheu, and Wen-Ter Lai
Division of Cardiology, Department of Internal Medicine,
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Acute respiratory distress syndrome (ARDS) is characterized by acute-onset dyspnea, diffuse bilateral
pulmonary infiltration, low pulmonary capillary wedge pressure (PCWP), and an arterial oxygen tension/
inspired oxygen fraction (PaO2/FiO2) ratio of less than 200 mmHg. Acute myocardial infarction (AMI),
whether complicated by circulatory arrest, cardiogenic shock, and hypotension or not, was reported as
an etiologic factor in the development of ARDS in the prethrombolytic era. In the thrombolytic era, two
cases of AMI complicated with ARDS have been reported. ARDS in these two patients resulted from
anaphylactic reaction to the thrombolytic agent and not from the hemodynamic consequences of AMI.
Development of ARDS during the AMI period has not been reported after early successful primary
percutaneous coronary intervention (PCI). Herein, we report a 61-year-old male patient with persistent
chest pain who was diagnosed with Killip II anterior ST-segment elevation AMI. He was treated successfully
with primary PCI 2.5 hours after the onset of chest pain. Unfortunately, on the third hospital day, acute-
onset dyspnea (respiratory rate, 33 beats/min), fever (38.5°C), leukocytosis (white blood cell count,
18,360/µL), and diffuse bilateral pulmonary infiltration were noted. ARDS was diagnosed from the low
PCWP (8 mmHg) and a PaO2/FiO2 of less than 200 mmHg (160 mmHg). No usual causes of ARDS such
as infection, aspiration, trauma, shock, or drug reactions were noted. We assumed that, in this particular
patient, the systemic inflammatory response syndrome frequently induced by AMI might have caused
this episode of ARDS. This may imply that AMI itself is a possible etiology of ARDS.
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Acute respiratory distress syndrome (ARDS) was first
described in 1967 by Ashbaugh et al in a heterogeneous
group of patients who presented with severe respiratory
failure [1]. Etiologies of ARDS can be divided into those
associated with infection, such as sepsis, and those not
linked to infection, including burns, hemorrhagic shock,
aspiration, drug reaction, and acute pancreatitis [2–6].
Another rare etiology that has been reported is acute
myocardial infarction (AMI) accompanied by circulatory
arrest, cardiogenic shock, or hypotension [7]. In the pre-
thrombolytic era, Yoshida et al reported a patient with
uncomplicated AMI who developed ARDS [8]. In the
thrombolytic era, two cases of AMI complicated with ARDS
have been reported, in which the ARDS resulted from
anaphylactic reaction to the thrombolytic agent and not
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from the hemodynamic consequence of AMI [9,10]. ARDS
developing during AMI is rare and the etiology is still not
clear. ARDS developing in patients with AMI after successful
treatment with primary percutaneous coronary intervention
(PCI) has not been reported. Herein, we report a 61-year-
old male patient with Killip II ST-segment elevation AMI
(STEMI) who received early successful primary PCI
treatment but developed ARDS on the third day after AMI.
CASE PRESENTATION
A 61-year-old male with persistent chest pain and cold
sweats was sent to our emergency room 1 hour after the
onset of typical chest pain. A 12-lead electrocardiogram
(ECG) showed ST-segment elevation in leads I, aVL, and
V1–V6 with reciprocal ST-segment depression in leads II,
III, and aVF. The pulse rate was 76 beats/min, blood pressure
was 108/74 mmHg, and physical examination revealed
a bilateral lower lung inspiratory crackle. These signs
and symptoms suggested Killip II anterior wall STEMI.
An anteroposterior view chest roentgenogram showed
mild cardiomegaly with pulmonary congestion (Figure
1A). The white blood cell count (WBC) was 14,790/µL,
hemoglobin concentration (Hb) was 16.1 g/dL, platelet
count (PLT) was 197,000/µL, aspartate aminotransferase
(AST) was 25 U/L, glutamate-pyruvate transaminase (GPT)
was 21 U/L, blood urea nitrogen (BUN) was 20 mg/dL,
serum creatinine (Cr) was 1.2 mg/dL, random sugar level
was 192 mg/dL, concentrations of Na, K, and Cl were
136, 4.2, and 102 mmol/L, prothrombin time (patient/
control) was 11.4/11.6 seconds (International Normalized
Ratio, 0.95), partial thromboplastin time (patient/control)
was 26.4/29.6 seconds, concentrations of serum creatine
kinase (CK) and myocardial bound CK (CK-MB) were 101
and 4.4 U/L, troponin-I concentration was 0.024 ng/mL,
C-reactive protein (CRP) was 75.7 mg/dL, cholesterol was
246 mg/dL, low-density lipoprotein cholesterol (LDL-C)
was 154 mg/dL, high-density lipoprotein cholesterol
(HDL-C) was 58 mg/dL, and triglyceride was 82 mg/dL.
Thirty minutes later, 1.5 hours after the onset of pain,
primary PCI was performed under heparin and glycopro-
tein IIb-IIIa receptor antagonist treatment. Coronary an-
giography revealed 50% discrete stenosis of the distal left
main artery, total occlusion of the proximal segment of the
left anterior descending artery (LAD), 80% discrete stenosis
of the middle segment of the left circumflex artery (Figure
2A), 30% discrete stenosis of the proximal segment of the
right coronary artery, and 50% discrete stenosis of the
posterior descending artery. The proximal part of the LAD
was designated as the infarct-related artery (IRA). The IRA
lesion was successfully recanalized by balloon angioplasty
(door to balloon time, 1.5 hours) and stent implantation
(Figure 2B).
Cardiac enzymes after admission showed a series of
changes with a peak CK/CK-MB of 7,955/352.5 U/L and a
peak troponin-I of 145.77 ng/mL at the 12th hour after the
onset of chest pain. Echocardiography showed anteroseptal
Figure 1. Chest roentgenograms: (A) in the emergency room, showing mild cardiomegaly with pulmonary congestion; (B) on the 3rd hospital day,
showing diffuse bilateral pulmonary infiltration with unchanged cardiac silhouette, clear costophrenic angle, no Kerley line, and no thickening of
minor fissure; (C) on the 13th hospital day, showing partial resolution of diffuse bilateral pulmonary infiltration.
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wall hypokinesia and mild mitral and tricuspid regurgita-
tion with fraction shortening of 28%. Unfortunately, on the
third hospital day, cough with a little white sputum and
respiratory distress with dyspnea (respiratory rate, 33
beats/min) were noted. Pulse rate was 110 beats/min, blood
pressure was 102/68 mmHg, and body temperature was
38.5°C. Cardiac examination showed no new pathologic
murmur, no jugular vein engorgement, and no S3 gallop,
but moist rales could be heard over the entire lung field.
Laboratory tests revealed the following: WBC, 18,360/µL;
Hb, 15.5 g/dL; PLT, 178,000/µL; CRP, 107.7 mg/dL; BUN/
Cr, 30/0.9 mg/dL; CK/CK-MB, 2,642/71.6 U/L; and
troponin-I, 71.95 ng/mL (continuous decrease). Oxygen
saturation (SaO2) was less than 90% under 6 L nasal oxy-
gen inhalation. A non-rebreathing mask (100%, 15 L) was
used to maintain the SaO2 at more than 90%. Arterial blood
gas analysis revealed a pH of 7.434, a partial pressure
of carbon dioxide (PCO2) of 37.5 mmHg, a partial oxygen
pressure (PaO2) of 144.2 mmHg, a bicarbonate concentra-
tion (HCO3) of 24.5 mmol/L, and SaO2 of 99.3%. Chest
roentgenogram showed diffuse bilateral pulmonary
infiltration (Figure 1B).
Pulmonary edema was suspected and intravenous
diuretic and nitrate were administered, but the dyspnea
persisted and diffuse infiltration on roentgenogram was
not ameliorated. In addition, the amount of urine was
maintained at more than 50 mL/hour, blood pressure was
more than 90/60 mmHg, and orthopnea, frothy sputum,
and paroxysmal nocturnal dyspnea were absent. Further-
more, acute mitral regurgitation and ventricular septal
rupture were excluded by echocardiography. Therefore,
pulmonary edema secondary to low cardiac output caused
by AMI was unlikely. A balloon-tipped, flow-directed
pulmonary arterial catheter (Swan-Ganz) was introduced
and revealed a cardiac index of 2.84 L/min/m2, pulmonary
capillary wedge pressure (PCWP) of only 8 mmHg, and
a systemic vascular resistance index of 2,204 dynes/sec/
cm–5/m2. ARDS was highly suspected from the clinical
presentation including low PCWP, a PaO2/inspired oxygen
fraction (FiO2) of 160 mmHg, diffuse bilateral pulmonary
infiltration, and acute onset of dyspnea. Possible etiologies
causing ARDS were surveyed. There were no aspiration or
trauma episodes. Multiple cultures obtained from blood,
urine, and sputum were all negative. Abdominal sono-
graphy showed no evidence of intra-abdominal infection.
Although there was no evidence of infection, empirical
antibiotics were used because of a high risk of superinfection.
Intravenous steroid was temporarily used for 2 days. Oxygen
therapy with a non-rebreathing mask (15 L, 100%) was used
for 6 days followed by a venturi mask (40%, 8 L) for 4 days,
before finally shifting to nasal cannula (2 L) use. Follow-up
chest roentgenogram on the 13th hospital day showed partial
Figure 2. Coronary angiograms: (A) left selective coronary angiography reveals 50% discrete stenosis of the distal left main artery, total occlusion
of the proximal segment of the left anterior descending artery (LAD) (arrow), and 80% discrete stenosis of the middle segment of the left circumflex
artery; (B) after successful primary percutaneous coronary intervention, left selective coronary angiography reveals no residual stenosis over the
proximal segment of the LAD.
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resolution of diffuse bilateral pulmonary infiltration (Figure
1C). He was weaned from the oxygen supply on the 16th
hospital day and discharged without event on day 17.
DISCUSSION
ARDS can occur with various disorders, divided into those
with direct injury to the lung and those causing indirect
injury in the setting of a systemic disease. Direct causes
include aspiration pneumonia, pulmonary contusion, toxic
inhalation, and near drowning. Indirect causes include
sepsis, shock, severe extrathoracic trauma, multiple frac-
tures, drug overdose, multiple transfusions, cardiopul-
monary bypass, eclampsia, burns, disseminated intravas-
cular coagulation, acute pancreatitis, and air or amniotic
fluid emboli [2–6]. As shown in the Table, there are rare case
reports suggesting that ARDS may occur during AMI.
Possible etiologies of ARDS were reported in six of these
cases while no specific etiology was found in one case. In
our case, there was no sepsis, trauma, gastric aspiration, or
blood transfusion during the admission period. Multiple
cultures obtained from sputum, urine, and blood were
negative. All these data indicated that the usual etiologies
of ARDS were not present in this patient. Our patient had
undergone primary PCI within the golden time so that the
degree of cardiac injury caused by AMI might have been
less than that without reperfusion therapy. The benefit of
this early intervention on cardiac function was supported
by the lower normal level of the cardiac index and
echocardiographic fraction shortening and normal PCWP.
However, ARDS occurred under this normal hemodynamic
status. Since there was no evidence of cardiogenic shock or
other apparent etiologies, the ARDS in this patient may be
attributed to the AMI disease process itself.
Inflammatory response leading to organ dysfunction
and failure continues to be a major problem after tissue
injury in many clinical conditions such as sepsis, acute
pancreatitis, hemorrhagic shock, trauma, and severe burns.
The systemic inflammatory response syndrome (SIRS) is an
entirely normal response to injury. Systemic leukocyte
activation is a direct consequence of SIRS and, if exten-
sive, can lead to distant organ damage and multiple organ
dysfunction syndrome (MODS) [11–13]. Acute lung injury
seen clinically as ARDS is a major manifestation of MODS
of various etiologies. Inflammatory mediators such as
interleukin-1 (IL-1), IL-6, tumor necrosis factor-α (TNF-α),
and intercellular adhesion molecule-1 (ICAM-1) play a key
role in the pathogenesis of ARDS [14]. A growing body
of experimental evidence suggests that inflammation is
involved in the pathogenesis of acute coronary syndromes
(ACS) and influences their clinical evolution. In patients
with ACS, the following systemic signs of inflammatory
reaction have been widely reported: activated circulating
inflammatory cells (neutrophil, monocytes, and lympho-
cytes) and increased concentrations of inflammatory
mediators such as IL-1, IL-6, TNF-α, ICAM-1, and CRP [15–
19]. In our case, although the true etiology of the ARDS was
undetermined, we assumed that SIRS induced by AMI
might have caused systemic leukocyte activation, which in
turn released extensive inflammatory mediators and caused
the ARDS.
Treatment of ARDS includes respiratory support,
underlying disease management, and therapy with
pharmacologic agents. Four phases have been reported in
the development of ARDS: the at-risk phase, acute
Table. Case reports of acute myocardial infarction (AMI) complicated with acute respiratory distress syndrome (ARDS)
Reference Age/Sex Type/Location of AMI Mode of reperfusion Possible etiology of ARDS
Keren et al [7] 83 /M NA/NA No reperfusion therapy Cardiac arrest
Keren et al [7] 63 /F NA/Anterior wall No reperfusion therapy Aspiration, cardiogenic shock
Keren et al [7] 56 /M NA/Inferoposterior wall No reperfusion therapy Hemorrhagic shock
Keren et al [7] 48 /M NA/Anterior wall No reperfusion therapy Smoke inhalation
Yoshida et al [8] 53 /F STEMI/Acute wall No reperfusion therapy No possible etiology
Le et al [9] 56 /M STEMI/Inferior and RV Thrombolytic therapy with APSAC drug reaction
involvement APSAC
Tio et al [10] 54 /M STEMI/Anterior wall Thrombolytic therapy with Streptokinase drug reaction
streptokinase
M = male; NA = not available; F = female; STEMI = ST-segment elevation myocardial infarction; RV = right ventricle; APSAC =
anisoylated plasminogen streptokinase activator complex.
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inflammatory phase, proliferative phase, and fibrotic phase.
Drug therapy needs to be considered according to the phase
of the disease progression [14,20]. Glucocorticoid may play
a role in the acute inflammatory and fibroproliferative
phases [21,22]. However, treatment with glucocorticoid in
AMI patients may interfere with healing of the injured
myocardium. Our patient temporarily received intravenous
steroid therapy for 2 days and dyspnea was improved. In
addition, aggressive oxygen therapy with non-rebreathing
and venturic masks was given and standard treatment
regimens for STEMI were administered. The patient
recovered without event and was discharged after 17 days
of management.
In conclusion, even though our patient had undergone
successful primary PCI in the golden time of AMI, ARDS
developed without apparent cause. We assumed that SIRS,
frequently induced by AMI, might have caused this episode
of ARDS, implying that AMI itself is a possible etiology of
ARDS.
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